vs

Side-by-side financial comparison of ARGENX SE (ARGX) and Vistra Corp. (VST). Click either name above to swap in a different company.

Vistra Corp. is the larger business by last-quarter revenue ($4.8B vs $2.5B, roughly 1.9× ARGENX SE). ARGENX SE runs the higher net margin — 35.5% vs 4.8%, a 30.6% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 31.2%). Vistra Corp. produced more free cash flow last quarter ($596.0M vs $322.4M).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Vistra may refer to either of two companies:Vistra, a corporate services company based in Hong Kong Vistra Corp, an energy company based in Texas

ARGX vs VST — Head-to-Head

Bigger by revenue
VST
VST
1.9× larger
VST
$4.8B
$2.5B
ARGX
Growing faster (revenue YoY)
ARGX
ARGX
+52.0% gap
ARGX
83.2%
31.2%
VST
Higher net margin
ARGX
ARGX
30.6% more per $
ARGX
35.5%
4.8%
VST
More free cash flow
VST
VST
$273.6M more FCF
VST
$596.0M
$322.4M
ARGX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARGX
ARGX
VST
VST
Revenue
$2.5B
$4.8B
Net Profit
$877.2M
$233.0M
Gross Margin
89.5%
Operating Margin
28.9%
9.9%
Net Margin
35.5%
4.8%
Revenue YoY
83.2%
31.2%
Net Profit YoY
1.3%
-47.2%
EPS (diluted)
$13.25
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARGX
ARGX
VST
VST
Q4 25
$2.5B
$4.8B
Q3 25
$4.8B
Q2 25
$1.8B
$3.8B
Q1 25
$4.3B
Q4 24
$1.4B
$3.7B
Q3 24
$4.3B
Q2 24
$901.9M
$3.6B
Q1 24
$3.2B
Net Profit
ARGX
ARGX
VST
VST
Q4 25
$877.2M
$233.0M
Q3 25
$652.0M
Q2 25
$414.8M
$327.0M
Q1 25
$-268.0M
Q4 24
$865.6M
$441.0M
Q3 24
$1.9B
Q2 24
$-32.5M
$365.0M
Q1 24
$-35.0M
Gross Margin
ARGX
ARGX
VST
VST
Q4 25
89.5%
Q3 25
Q2 25
89.2%
Q1 25
Q4 24
90.2%
Q3 24
Q2 24
89.4%
Q1 24
Operating Margin
ARGX
ARGX
VST
VST
Q4 25
28.9%
9.9%
Q3 25
21.7%
Q2 25
19.2%
13.7%
Q1 25
-2.8%
Q4 24
8.7%
16.4%
Q3 24
59.6%
Q2 24
-15.4%
22.5%
Q1 24
2.7%
Net Margin
ARGX
ARGX
VST
VST
Q4 25
35.5%
4.8%
Q3 25
13.6%
Q2 25
23.4%
8.7%
Q1 25
-6.3%
Q4 24
64.1%
12.0%
Q3 24
43.5%
Q2 24
-3.6%
10.1%
Q1 24
-1.1%
EPS (diluted)
ARGX
ARGX
VST
VST
Q4 25
$13.25
$0.55
Q3 25
$1.75
Q2 25
$6.32
$0.81
Q1 25
$-0.93
Q4 24
$13.33
$1.09
Q3 24
$5.25
Q2 24
$-0.55
$0.90
Q1 24
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARGX
ARGX
VST
VST
Cash + ST InvestmentsLiquidity on hand
$3.5B
$785.0M
Total DebtLower is stronger
$15.8B
Stockholders' EquityBook value
$7.3B
$5.1B
Total Assets
$8.7B
$41.5B
Debt / EquityLower = less leverage
3.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARGX
ARGX
VST
VST
Q4 25
$3.5B
$785.0M
Q3 25
$602.0M
Q2 25
$2.1B
$458.0M
Q1 25
$561.0M
Q4 24
$1.5B
$1.2B
Q3 24
$905.0M
Q2 24
$1.4B
$1.6B
Q1 24
$1.1B
Total Debt
ARGX
ARGX
VST
VST
Q4 25
$15.8B
Q3 25
$15.8B
Q2 25
$15.5B
Q1 25
$15.4B
Q4 24
$15.4B
Q3 24
$13.9B
Q2 24
$11.0M
$13.9B
Q1 24
$14.7B
Stockholders' Equity
ARGX
ARGX
VST
VST
Q4 25
$7.3B
$5.1B
Q3 25
$5.2B
Q2 25
$6.1B
$4.8B
Q1 25
$4.8B
Q4 24
$5.5B
$5.6B
Q3 24
$5.4B
Q2 24
$4.3B
$5.6B
Q1 24
$5.7B
Total Assets
ARGX
ARGX
VST
VST
Q4 25
$8.7B
$41.5B
Q3 25
$38.0B
Q2 25
$7.2B
$38.1B
Q1 25
$38.2B
Q4 24
$6.2B
$37.8B
Q3 24
$37.9B
Q2 24
$4.8B
$39.1B
Q1 24
$38.2B
Debt / Equity
ARGX
ARGX
VST
VST
Q4 25
3.11×
Q3 25
3.02×
Q2 25
3.22×
Q1 25
3.20×
Q4 24
2.77×
Q3 24
2.56×
Q2 24
0.00×
2.49×
Q1 24
2.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARGX
ARGX
VST
VST
Operating Cash FlowLast quarter
$323.3M
$1.4B
Free Cash FlowOCF − Capex
$322.4M
$596.0M
FCF MarginFCF / Revenue
13.0%
12.4%
Capex IntensityCapex / Revenue
0.0%
17.4%
Cash ConversionOCF / Net Profit
0.37×
6.15×
TTM Free Cash FlowTrailing 4 quarters
$594.5M
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARGX
ARGX
VST
VST
Q4 25
$323.3M
$1.4B
Q3 25
$1.5B
Q2 25
$361.8M
$572.0M
Q1 25
$599.0M
Q4 24
$41.9M
$1.4B
Q3 24
$1.7B
Q2 24
$-124.7M
$1.2B
Q1 24
$312.0M
Free Cash Flow
ARGX
ARGX
VST
VST
Q4 25
$322.4M
$596.0M
Q3 25
$1.0B
Q2 25
$356.6M
$-118.0M
Q1 25
$-169.0M
Q4 24
$40.9M
$923.0M
Q3 24
$1.0B
Q2 24
$-125.5M
$698.0M
Q1 24
$-153.0M
FCF Margin
ARGX
ARGX
VST
VST
Q4 25
13.0%
12.4%
Q3 25
21.1%
Q2 25
20.1%
-3.1%
Q1 25
-4.0%
Q4 24
3.0%
25.2%
Q3 24
23.4%
Q2 24
-13.9%
19.4%
Q1 24
-4.8%
Capex Intensity
ARGX
ARGX
VST
VST
Q4 25
0.0%
17.4%
Q3 25
9.6%
Q2 25
0.3%
18.4%
Q1 25
18.1%
Q4 24
0.1%
11.7%
Q3 24
15.8%
Q2 24
0.1%
13.8%
Q1 24
14.7%
Cash Conversion
ARGX
ARGX
VST
VST
Q4 25
0.37×
6.15×
Q3 25
2.25×
Q2 25
0.87×
1.75×
Q1 25
Q4 24
0.05×
3.07×
Q3 24
0.90×
Q2 24
3.28×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARGX
ARGX

Segment breakdown not available.

VST
VST

Retail Energy Charge In ERCOT$2.1B43%
Retail Energy Charge In Northeast Midwest$1.2B24%
East Segment$1.1B24%
Hedging Revenue Realized$170.0M4%
Revenue From Other Wholesale Contracts$116.0M2%
Transferable Production Tax Credit Revenues$78.0M2%
West Segment$77.0M2%
Intersegment Sales$25.0M1%

Related Comparisons